MedTrace Logo

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

NCT04322734 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-04-23

No results posted yet for this study

Summary

The study involves up to 5 visits for a fasting blood draw, behavioral assessments, and/or questionnaires. Other samples may be collected when appropriate.

This study is currently recruiting.

There is no cost for visits or study-related exams.

Conditions

Sponsors & Collaborators

  • State University of New York - Downstate Medical Center

    collaborator OTHER

  • Southwest Autism Research & Resource Center

    lead OTHER

Principal Investigators

  • Richard E Frye, MD, PhD · Autism Discovery & Treatment Foundation

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-13
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04322734 on ClinicalTrials.gov